IL165033A0 - Bioactivation of particles - Google Patents

Bioactivation of particles

Info

Publication number
IL165033A0
IL165033A0 IL16503303A IL16503303A IL165033A0 IL 165033 A0 IL165033 A0 IL 165033A0 IL 16503303 A IL16503303 A IL 16503303A IL 16503303 A IL16503303 A IL 16503303A IL 165033 A0 IL165033 A0 IL 165033A0
Authority
IL
Israel
Prior art keywords
bioactivation
particles
Prior art date
Application number
IL16503303A
Other languages
English (en)
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IL165033A0 publication Critical patent/IL165033A0/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Mathematical Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL16503303A 2002-05-07 2003-05-07 Bioactivation of particles IL165033A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37872002P 2002-05-07 2002-05-07
PCT/US2003/014401 WO2004039830A2 (en) 2002-05-07 2003-05-07 Bioactivation of particles

Publications (1)

Publication Number Publication Date
IL165033A0 true IL165033A0 (en) 2005-12-18

Family

ID=32230082

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16503303A IL165033A0 (en) 2002-05-07 2003-05-07 Bioactivation of particles

Country Status (6)

Country Link
US (2) US7998923B2 (enExample)
EP (1) EP1521589A4 (enExample)
JP (1) JP2006508095A (enExample)
AU (1) AU2003299478A1 (enExample)
IL (1) IL165033A0 (enExample)
WO (1) WO2004039830A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1521589A4 (en) 2002-05-07 2008-06-04 Univ California BIOACTIVATION OF PARTICLES
WO2005053649A1 (en) 2003-11-05 2005-06-16 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Biofunctionalized quantum dots for biological imaging
WO2006093516A2 (en) 2004-06-22 2006-09-08 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
JP2008510852A (ja) 2004-08-17 2008-04-10 インヴィトロジェン コーポレーション 高発光性コロイド粒子の合成
CA2582668C (en) * 2004-10-01 2013-10-01 Midatech Ltd Nanoparticles comprising antigens and adjuvants, and immunogenic structures
US7368086B2 (en) * 2004-10-29 2008-05-06 Invitrogen Corporation Functionalized fluorescent nanocrystals, and methods for their preparation and use
JP2006182673A (ja) * 2004-12-27 2006-07-13 Kenji Yamamoto マーカー付き医薬
JP4854678B2 (ja) * 2005-01-17 2012-01-18 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 新規水溶性ナノクリスタルおよびその調製方法
WO2006104464A1 (en) * 2005-03-31 2006-10-05 Agency For Science, Technology And Research Cdte/gsh core-shell quantum dots
EP1900822B1 (en) * 2005-05-24 2016-02-03 Suzuki, Miho Method for simultaneous analysis of multiple biological reactions or changes in in vivo conditions
EP1894003A2 (en) 2005-06-07 2008-03-05 Koninklijke Philips Electronics N.V. In vivo expression profiling
DK1928423T3 (en) * 2005-09-14 2016-02-29 Mannkind Corp A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces
EP1998684A4 (en) * 2006-03-10 2014-09-17 Massachusetts Inst Technology CONJUGATES AND NANOSYSTEMS WITH TRIGGERED SELF ASSEMBLY
US8216549B2 (en) * 2008-07-25 2012-07-10 National Health Research Institutes Method for making a ligand-quantum dot conjugate
WO2012153820A1 (ja) * 2011-05-12 2012-11-15 コニカミノルタエムジー株式会社 X線吸収蛍光ナノ粒子
CN107502003B (zh) * 2016-06-14 2020-06-02 中国科学院理化技术研究所 一种疏水无机粉体材料的制备方法
CN111184874B (zh) * 2018-11-14 2022-02-22 南京大学 疏水性纳米生物探针

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US166505A (en) * 1875-08-10 Improvement in locks for sliding doors
US150905A (en) * 1874-05-12 Improvement in devices for operating street-car doors
US28457A (en) * 1860-05-29 James deally
US175773A (en) * 1876-04-04 Improvement in shawl-strap handles
US129591A (en) * 1872-07-16 Improvement in hinges
US99940A (en) * 1870-02-15 Improvement in shingle-machine
US7169A (en) * 1850-03-12 Cast-ibobt cae-wheel
US8414A (en) * 1851-10-07 Machine for cutting screws on posts and nails of bedsteads
US82237A (en) * 1868-09-15 Josiah f
US34034A (en) * 1861-12-24 Improvement in bee-hives
US9911A (en) * 1853-08-02 Improvement in elastic type for printing on irregular surfaces
US129590A (en) * 1872-07-16 Improvement in wheels for vehicles
US14060A (en) * 1856-01-08 Pecr-cutteb
US54004A (en) * 1866-04-17 Improvement in bridges
US9728A (en) * 1853-05-17 Cooking-stove
US23415A (en) * 1859-03-29 Improvement in clod-crushers
US38307A (en) * 1863-04-28 Improved washing-machine
US158051A (en) * 1874-12-22 Improvement in finger-bars for harvesters
US253211A (en) * 1882-02-07 Carrier attachment for bicycles
US59031A (en) * 1866-10-23 Improvement in machines for molding, felting, and fulling hat-bodies
US171039A (en) * 1875-12-14 Improvement in saw-gummers
US165951A (en) * 1875-07-27 Improvement in folding tables
US113709A (en) * 1871-04-11 Improvement in shovel-handles
US27214A (en) * 1860-02-21 Improvement in sewing-machines
US180380A (en) * 1876-07-25 Improvement in hangings for sliding and swinging gates
US127224A (en) * 1872-05-28 Improvement in cotton-seed cleaners
US148544A (en) * 1874-03-17 Improvement in machines for making hollow cylinders of paper
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5512332A (en) 1985-10-04 1996-04-30 Immunivest Corporation Process of making resuspendable coated magnetic particles
US5698271A (en) 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5541072A (en) 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
US5466574A (en) 1991-03-25 1995-11-14 Immunivest Corporation Apparatus and methods for magnetic separation featuring external magnetic means
US5186827A (en) 1991-03-25 1993-02-16 Immunicon Corporation Apparatus for magnetic separation featuring external magnetic means
US5795470A (en) 1991-03-25 1998-08-18 Immunivest Corporation Magnetic separation apparatus
US5505928A (en) 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US5262357A (en) 1991-11-22 1993-11-16 The Regents Of The University Of California Low temperature thin films formed from nanocrystal precursors
JPH07502479A (ja) 1991-11-22 1995-03-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 自己集合性単一層を使って固体無機表面に共有結合した半導体微少結晶
US5567326A (en) 1994-09-19 1996-10-22 Promega Corporation Multisample magnetic separation device
US6506564B1 (en) 1996-07-29 2003-01-14 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
BR9907852A (pt) 1998-02-12 2000-10-24 Immunivest Corp Processos para detectar e enumerar células raras e cancerosas em uma população celular mista, para diagnosticar câncer de estágio precoce em um paciente de teste, para determinar a probabilidade de recorrência de câncer em um paciente humano anteriormente tratado de câncer, para distinguir um carcinoma confinado ao órgão de um carcinoma com propriedades metastáticas, para acompanhar a situação de remissão em um paciente humano com câncer que passa pelo tratamento de terapia contra o câncer e para aumentar quantidades de células epiteliais circulantes em uma amostra de sangue, partìcula magnética revestida, composição, conjuntos de teste para avaliar uma amostra de paciente quanto a presença de células raras circulantes, quanto a presença de células de tumor circulantes, quanto a presença de células de câncer de mama circulantes, quanto a presença de células de câncer de próstata circulantes, quanto a presença de células de câncer de cólon circulantes, quanto a presença de células de câncer de bexiga circulantes e para monitorar um paciente quanto a recorrência de câncer, e, fração de sangue periférico enriquecido quanto a células neoplásticas circulantes
US6326144B1 (en) 1998-09-18 2001-12-04 Massachusetts Institute Of Technology Biological applications of quantum dots
US6306610B1 (en) 1998-09-18 2001-10-23 Massachusetts Institute Of Technology Biological applications of quantum dots
EP2306195A3 (en) * 1998-09-18 2012-04-25 Massachusetts Institute of Technology Biological applications of semiconductor nanocrystals
WO2000017642A2 (en) 1998-09-18 2000-03-30 Massachusetts Institute Of Technology Biological applications of semiconductor nanocrystals
US6251303B1 (en) 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
JP4404489B2 (ja) 1998-09-18 2010-01-27 マサチューセッツ インスティテュート オブ テクノロジー 水溶性蛍光半導体ナノ結晶
JP4630459B2 (ja) 1998-09-24 2011-02-09 インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション 水溶性発光量子ドットおよびその生体分子コンジュゲート
WO2000027365A1 (en) * 1998-11-10 2000-05-18 Biocrystal Limited Functionalized nanocrystals and their use in detection systems
US6221602B1 (en) * 1998-11-10 2001-04-24 Bio-Pixels Ltd. Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination
US6333110B1 (en) 1998-11-10 2001-12-25 Bio-Pixels Ltd. Functionalized nanocrystals as visual tissue-specific imaging agents, and methods for fluorescence imaging
US6114038A (en) 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems
US6261779B1 (en) 1998-11-10 2001-07-17 Bio-Pixels Ltd. Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
US6319607B1 (en) * 1998-11-10 2001-11-20 Bio-Pixels Ltd. Purification of functionalized fluorescent nanocrystals
US20030027214A1 (en) 1999-02-17 2003-02-06 Kamb Carl Alexander Methods for substrate-ligand interaction screening
ATE439452T1 (de) 1999-05-07 2009-08-15 Life Technologies Corp Verfahren zum nachweis von analyten mit hilfe von halbleiternanokrystallen
US6544732B1 (en) 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
US6623982B1 (en) 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
US6194213B1 (en) 1999-12-10 2001-02-27 Bio-Pixels Ltd. Lipophilic, functionalized nanocrystals and their use for fluorescence labeling of membranes
EP1294930B1 (en) 2000-01-13 2011-03-30 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
WO2003074738A1 (en) 2000-01-18 2003-09-12 Quantom Dot Corporation Oligonucleotide-tagged semiconductor nanocrystals for microarray and fluorescence in situ hybridization
US20030099940A1 (en) 2000-02-16 2003-05-29 Empedocles Stephen A. Single target counting assays using semiconductor nanocrystals
US20020028457A1 (en) 2000-02-16 2002-03-07 Quantum Dot Corporation Single target counting assays using semiconductor nanocrystals
EP2365096A1 (en) 2000-03-22 2011-09-14 Life Technologies Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
US6838243B2 (en) 2000-04-28 2005-01-04 Quantum Dot Corporation Methods and compositions for polynucleotide analysis using generic capture sequences
AU5835801A (en) 2000-05-05 2001-11-20 Bayer Ag Doped nanoparticles as biolabels
US20030129591A1 (en) 2000-05-24 2003-07-10 Rosenthall Sandra J. Linker arms for nanocrystals and compounds thereof
US20030129590A1 (en) 2000-05-24 2003-07-10 Rosenthall Sandra J. Linker arms for nanocrystals and compounds thereof
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US20020127224A1 (en) 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
JP2005508493A (ja) 2001-06-28 2005-03-31 アドヴァンスト リサーチ アンド テクノロジー インスティテュート、インコーポレイティッド 多色量子ドット標識ビーズおよびそのコンジュゲートの製造方法
CA2453450A1 (en) 2001-07-20 2003-11-06 Quantum Dot Corporation Luminescent nanoparticles and methods for their preparation
US7205048B2 (en) 2001-09-17 2007-04-17 Invitrogen Corporation Functionalized fluorescent nanocrystal compositions and methods of making
EP1456022B1 (en) 2001-09-17 2009-11-11 Life Technologies Corporation Nanocrystals
US7214428B2 (en) 2001-09-17 2007-05-08 Invitrogen Corporation Highly luminescent functionalized semiconductor nanocrystals for biological and physical applications
AU2002365255A1 (en) 2001-10-02 2003-09-02 The Regents Of The University Of California Nanoparticle assembled hollow spheres
US8889414B2 (en) 2001-10-31 2014-11-18 The Regents Of The University Of California Semiconductor nanocrystal-based phagokinetic tracking
US20040007169A1 (en) 2002-01-28 2004-01-15 Mitsubishi Chemical Corporation Semiconductor nanoparticles and thin film containing the same
US20040009911A1 (en) 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
DE60325564D1 (de) 2002-03-05 2009-02-12 Univ Texas Biospezifische kontrastmittel
EP1521589A4 (en) 2002-05-07 2008-06-04 Univ California BIOACTIVATION OF PARTICLES
WO2004046164A2 (en) 2002-05-10 2004-06-03 Engeneos, Inc. Unique recognition sequences and methods of use thereof in protein analysis
US7460960B2 (en) 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7534488B2 (en) 2003-09-10 2009-05-19 The Regents Of The University Of California Graded core/shell semiconductor nanorods and nanorod barcodes
US20040158051A1 (en) 2002-11-19 2004-08-12 Mihri Ozkan Mono and dual conjugation of nanostructures and methods of making and using thereof
US20070275007A1 (en) 2003-11-05 2007-11-29 The Government Of The United States Of America, Represented By The Secretary Of Health And Human S Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
WO2005053649A1 (en) 2003-11-05 2005-06-16 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Biofunctionalized quantum dots for biological imaging
WO2006093516A2 (en) 2004-06-22 2006-09-08 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
US7368086B2 (en) 2004-10-29 2008-05-06 Invitrogen Corporation Functionalized fluorescent nanocrystals, and methods for their preparation and use

Also Published As

Publication number Publication date
US20120208023A1 (en) 2012-08-16
EP1521589A2 (en) 2005-04-13
US20080281079A1 (en) 2008-11-13
WO2004039830A2 (en) 2004-05-13
EP1521589A4 (en) 2008-06-04
AU2003299478A1 (en) 2004-05-25
WO2004039830A3 (en) 2005-02-10
US7998923B2 (en) 2011-08-16
AU2003299478A8 (en) 2004-05-25
JP2006508095A (ja) 2006-03-09

Similar Documents

Publication Publication Date Title
AU2003293294A8 (en) Uv-stabilised particles
GB0216197D0 (en) Serrs active particles
AU2003225901A8 (en) Stabilized inorganic particles
EP1578394A4 (en) ANTIBODY PARTICLES AND COMPOSITIONS
PL371526A1 (en) Phosphorus-containing compounds and uses thereof
EP1575495A4 (en) COMPOUNDS AND METHODS
GB0229742D0 (en) Novel compounds and uses thereof
AU2003256805A8 (en) Compounds compositions and methods
GB0223127D0 (en) nanoparticles
AU2003299478A8 (en) Bioactivation of particles
GB2398241B (en) Particle formation
IL166331A0 (en) 5-arylterazole compounds compositions thereof and uses therefor
GB2391174B (en) Particle formation
AU2003291443A8 (en) Compositions and processes for nanoimprinting
EP1699435A4 (en) PARTICLE
GB0223149D0 (en) Nanoparticles
GB0324147D0 (en) Functionilisation of particles
IL164154A0 (en) Fine particle size pioglitazone
AU2003237268A1 (en) Ultrafine hexagonal fertrite particles
AU2003242064A1 (en) Magnetite particles
GB0201382D0 (en) Virus-like particles
GB0300338D0 (en) Particle formation
GB0221999D0 (en) Coated metallurgical particles
AU2003234599A8 (en) Methods and compounds for reducing biofilm formation
GB0224058D0 (en) Modelling and design integration